Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A Labour Party official said he’d like to see legislation that heavily impacts imports of Chinese textiles — a potential problem for Shein.
Days after industrial workers in its Pacific Northwest plants voted to approve a labor strike, Boeing instituted a hiring freeze.
ispace plans to launch a second attempt to land a probe on the moon later this year, with a new record in mind.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
McDonald’s announced that its $5 summer meal deal, which was only supposed to last through June, will now be extended into December.
Moderna walked a tightrope trying to convince shareholders it can both develop a new portfolio of drugs and keep costs down in the process.
AI has a lot of promise in the healthcare industry in areas such as documentation, imaging, and quicker diagnostics as staffing shortages loom.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
With rising valuations, sports team ownership should be a slam dunk. But it’s also possible those valuations are a little rich.
Elliott Management ousted much of the board at Southwest Airlines, with Gary Kelly announcing his retirement amid broader board turnover.
Shares in major video game publisher Ubisoft took an over 7% hit on Monday after a minor investor’s letter.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.